AstraZeneca Pharma India Limited (ASTRAZEN.NS)
NSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹6,073.00 (+0.36%) as of
Key statistics
- Market cap
- 151.83B
- P/E (TTM)
- 89.51
- EPS (TTM)
- 67.85
- Dividend yield
- 0.59%
- 52-week range
- 5,640.00 – 9,849.50
- Beta
- 0.23
- Revenue (TTM)
- 24.32B
- Profit margin
- 6.97%
- Volume
- 5.04k
About AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Bengaluru, India
- Employees
- 600
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.